eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese.
| Title | eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese. |
| Publication Type | Journal Article |
| Year of Publication | 2013 |
| Authors | Triantafyllou, A., Pyrpasopoulou A., Anyfanti P., Balaska E., Aslanidis S., & Douma S. |
| Journal | Ann Rheum Dis |
| Volume | 72 |
| Issue | 5 |
| Pagination | e7 |
| Date Published | 2013 May |
| ISSN | 1468-2060 |
| Keywords | Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Arthritis, Rheumatoid, B-Cell Activating Factor, Humans, Tumor Necrosis Factor-alpha |
| DOI | 10.1136/annrheumdis-2013-203240 |
| Alternate Journal | Ann Rheum Dis |
| PubMed ID | 23396663 |
